These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 7120130

  • 1. Cardiovascular pharmacology of ASL-7022, a novel catecholamine. I. Inotropic, chronotropic and pressor actions.
    Gorczynski RJ.
    J Pharmacol Exp Ther; 1982 Oct; 223(1):7-11. PubMed ID: 7120130
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular pharmacology of ASL-7022. II. Mechanisms of inotropic selectivity.
    Gorczynski RJ, Wroble RW.
    J Pharmacol Exp Ther; 1982 Oct; 223(1):12-9. PubMed ID: 6126579
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms.
    Gorczynski RJ, Reynolds RD.
    J Pharmacol Exp Ther; 1985 Mar; 232(3):629-35. PubMed ID: 2857783
    [Abstract] [Full Text] [Related]

  • 4. Integrative cardiovascular actions of a novel catecholamine, GP-2-128.
    Abou-Mohamed G, Caldwell RW, Ibrahim TM, Tuttle RR.
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):485-91. PubMed ID: 7515995
    [Abstract] [Full Text] [Related]

  • 5. Chronotropic and inotropic responses to ASL-7022 on isolated rat atria.
    Gende OA, Camilión de Hurtado MC.
    Acta Physiol Pharmacol Latinoam; 1989 Mar; 39(2):119-26. PubMed ID: 2618750
    [Abstract] [Full Text] [Related]

  • 6. The inotropic actions of N-acetylprocainamide: blockade and reversal by propranolol.
    Lertora JJ, King LW, Donkor KA.
    Angiology; 1986 Dec; 37(12 Pt 2):939-49. PubMed ID: 2433968
    [Abstract] [Full Text] [Related]

  • 7. [General pharmacological actions of traxanox sodium. II. Effects on the cardiovascular system].
    Nakamura T, Miura Y, Aihara K, Satoh H, Goto K, Tsumagari T.
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):79-92. PubMed ID: 6137441
    [Abstract] [Full Text] [Related]

  • 8. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ, Haitsma DB, van der Geest IE, Stubenitsky R, van Meegen JR, Man in't Veld AJ, Verdouw PD.
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [Abstract] [Full Text] [Related]

  • 9. Beta-blocking and hemodynamic effects of ASL-8052.
    Gorczynski RJ, Murthy VS, Hwang TF.
    J Cardiovasc Pharmacol; 1984 Mar; 6(6):1548-59. PubMed ID: 6084788
    [Abstract] [Full Text] [Related]

  • 10. Interaction of the novel inotropic agent, ASL-7022, with alpha and beta adrenoceptors in the cardiovascular system of the pithed rat: comparison with dobutamine and dopamine.
    Ruffolo RR, Morgan EL.
    J Pharmacol Exp Ther; 1984 May; 229(2):364-71. PubMed ID: 6325661
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
    Bass AS, Kohli JD, Lubbers N, Goldberg LI.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):940-4. PubMed ID: 2888876
    [Abstract] [Full Text] [Related]

  • 14. The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs.
    Setler PE, Pendleton RG, Finlay E.
    J Pharmacol Exp Ther; 1975 Mar; 192(3):702-12. PubMed ID: 1120964
    [Abstract] [Full Text] [Related]

  • 15. Possible involvement of indirect mechanism in cardiovascular action of dobutamine in dogs.
    Morishita H, Furukawa T.
    Arch Int Pharmacodyn Ther; 1979 May; 239(1):121-7. PubMed ID: 485708
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines.
    Liang C, Doherty JU, Faillace R, Maekawa K, Arnold S, Gavras H, Hood WB.
    J Clin Invest; 1982 Jun; 69(6):1321-36. PubMed ID: 6123523
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y, Kawada M, Sawanobori K, Sonoki H, Inoue K, Mizuno K, Itou T, Tabunoki Y, Tsukamoto M, Ohashi Y, Kyotani Y, Shimizu N, Fujii M, Nakamura M.
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [Abstract] [Full Text] [Related]

  • 19. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
    Hirose M, Furukawa Y, Kurogouchi F, Nakajima K, Miyashita Y, Chiba S.
    J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843
    [Abstract] [Full Text] [Related]

  • 20. Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.
    Hashimoto K, Yabuuchi Y, Yamashita S, Mori T.
    Arzneimittelforschung; 1984 Jul; 34(3A):390-3. PubMed ID: 6540094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.